Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma

World Journal of Gastroenterology

Volumn 14, Issue 10, 2008, Pages 1582-1587

  Zhou, Chong Zhi ^a   Qiu, Guo Qiang ^a   Fan, Jun wei ^a   Wang, Xiao Liang ^a   Tang, Hua Mei ^a   Huang, Li ^a   Sun, Yu Hao ^a   Peng, Zhi Hai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

1q31.1 32.1; Loss of heterozygosity; Sporadic colorectal carcinoma; Tumor suppressor genes

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME 1Q; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; ELECTROPHORESIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 41549142245     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1582     Document Type: Article

References (37)

1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
3. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinomas. Science 1989; 244: 207-211
4. Fearon ER. Molecular genetics of colorectal cancer. Ann N Y Acad Sci 1995; 768: 101-110
5. Lasko D, Cavenee W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 1991; 25: 281-314
6. Solomon E, Voss R, Hall V, Bodmer WF, Jass JR, Jeffreys AJ, Lucibello FC, Patel I, Rider SH. Chromosome 5 allele loss in human colorectal carcinomas. Nature 1987; 328: 616-619
7. van der Bosch K, Becker I, Savelyeva L, Bruderlein S, Schlag P, Schwab M. Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chromosomes Cancer 1992; 5: 91-95
8. Monpezat JP, Delattre O, Bernard A, Grunwald D, Remvikos Y, Muleris M, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas. Int J Cancer 1988; 41: 404-408
9. Lanza G, Matteuzzi M, Gafa R, Orvieto E, Maestri I, Santini A, del Senno L. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 1998; 79: 390-395
10. Weber TK, Conroy J, Keitz B, Rodriguez-Bigas M, Petrelli NJ, Stoler DL, Anderson GR, Shows TB, Nowak NJ. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer. Cytogenet Cell Genet 1999; 86: 142-147
11. Zhou CZ, Peng ZH, Zhang F, Qiu GQ, He L. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J Gastroenterol 2002; 8: 668-673
12. Stella A, Resta N, Gentile M, Susca F, Mareni C, Montera MP, Guanti G. Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP). Am J Hum Genet 1993; 53: 1031-1037
13. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986; 320: 84-85
14. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA, Vogelstein B. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 1994; 19: 525-531
15. Sieben NL, ter Haar NT, Cornelisse CJ, Fleuren GJ, Cleton-Jansen AM. PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol 2000; 31: 1414-1419
16. Fromont G, Vallancien G, Validire P, Levillain P, Cussenot O. BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining. Prostate 2007; 67: 268-273
17. Peng Z, Zhang F, Zhou C, Ling Y, Bai S, Liu W, Qiu G, He L, Wang L, Wei D, Lin E, Xie K. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer. Int J Gastrointest Cancer 2003; 34: 39-48
18. Zhou CZ, Qiu GQ, Zhang F, He L, Peng ZH. Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol 2004; 10: 1431-1435
19. Vasen HF, Griffioen C, Offerhaus GJ, Den Hartog Jager FC, Van Leeuwen-Cornelisse IS, Meera Khan P, Lamers CB, Van Slooten EA. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands. Dis Colon Rectum 1990; 33: 227-230
20. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456
21. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976; 3: 2303-2308
22. Zheng HT, Peng ZH, Zhou CZ, Li DP, Wang ZW, Qiu GQ, He L. Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer. World J Gastroenterol 2005; 11: 1668-1672
23. Xu SF, Peng ZH, Li DP, Qiu GQ, Zhang F. Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer. World J Gastroenterol 2003; 9: 1713-1718
24. Peng Z, Zhou C, Zhang F, Ling Y, Tang H, Bai S, Liu W, Qiu G, He L. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer. Chin Med J (Engl) 2002; 115: 1529-1532
25. Kyndi M, Alsner J, Hansen LL, Sorensen FB, Overgaard J. LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer. Acta Oncol 2006; 45: 602-609
26. Huang Z, Wen Y, Shandilya R, Marks JR, Berchuck A, Murphy SK. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. Nucleic Acids Res 2006; 34: 555-563
27. Sanchez de Abajo A, de la Hoya M, van Puijenbroek M, Godino J, Diaz-Rubio E, Morreau H, Caldes T. Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer? Oncogene 2006; 25: 2124-2130
28. Woenckhaus M, Grepmeier U, Wild PJ, Merk J, Pfeifer M, Woenckhaus U, Stoelcker B, Blaszyk H, Hofstaedter F, Dietmaier W, Hartmann A. Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium. Am J Clin Pathol 2005; 123: 752-761
29. Zhou CZ, Zheng HT, Qiu GQ, Zhang F, He L, Peng ZH. Refined mapping of loss of heterozygosity of 1p36.33-36.31 in sporadic colorectal carcinoma. Zhonghua Yixue Zazhi 2006; 86: 1804-1807
30. Benitez J, Osorio A, Barroso A, Arranz E, Diaz-Guillen MA, Robledo M, Rodriguez de Cordoba S, Heine-Suner D. A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spot. Cancer Res 1997; 57: 4217-4220
31. Pietsch T, Koch A, Wiestler OD. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p23. Klin Padiatr 1997; 209: 150-155
32. Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Genes Chromosomes Cancer 2000; 27: 244-251
33. Yang YM, Liu TH, Chen YJ, Jiang WJ, Qian JM, Lu X, Gao J, Wu SF, Sang XT, Chen J. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy. Int J Cancer 2005; 117: 234-240
34. Li J, Liu Z, Wang Y, Yu Z, Wang M, Zhan Q, Liu Z. Allelic imbalance of chromosome 1q in esophageal squamous cell carcinomas from China: a novel region of allelic loss and significant association with differentiation. Cancer Lett 2005; 220: 221-230
35. Dube JY, Chapdelaine P, Trahan PL, Deperthes D, Frenette G, Tremblay RR. Abundant cysteine-rich protein-1 is localized in the stromal compartment of the human prostate. Arch Androl 1998; 40: 109-115
36. Wang X, Ray K, Szpirer J, Levan G, Liebhaber SA, Cooke NE. Analysis of the human cysteine-rich protein gene (CSRP), assignment to chromosome 1q24-1q32, and identification of an associated MspI polymorphism. Genomics 1992; 14: 391-397
37. Hirasawa Y, Arai M, Imazeki F, Tada M, Mikata R, Fukai K, Miyazaki M, Ochiai T, Saisho H, Yokosuka O. Methylation status of genes upregulated by demethylating agent 5-aza-2′-deoxycytidine in hepatocellular carcinoma. Oncology 2006; 71: 77-85